Plain-English translation of NCT07085221 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether HeartMed-HF, a digital app that monitors your heart health from home, helps patients who have had early cardiogenic shock (a serious condition where the heart suddenly can't pump enough blood) recover better after hospital discharge. Half of the patients will use this app to stay connected with their care team, while the other half will receive standard discharge instructions. Researchers will track both groups for one year to see if using the app reduces deaths and unplanned hospital readmissions.
Patients who have experienced cardiogenic shock are at high risk for serious complications after they leave the hospital. This trial is testing whether keeping patients connected to their doctors through digital monitoring helps catch problems early and prevent readmissions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either the app group or the standard care group. If you are in the app group, you will use the HeartMed-HF app on your smartphone to track your health at home and communicate with your care team. Both groups will have follow-up visits or check-ins at 3 months, 6 months, and 12 months after you leave the hospital. Researchers will monitor your health outcomes, hospitalizations, and medications throughout the year.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
China